In support, targeting Emmprin, LYVE-1, or BCRP by RNA interference promoted PEL cell apoptosis induced by chemotherapy while the overexpression of Emmprin greatly enhanced the resistance of chemosensitive tumor cells to paclitaxel and doxorubicin [39,96]. Here, BSG is linked to neoplasm.